Overview
Oriental Ocean
?
Le Zhang
See more contacts
Aquaculture
,
Seafood Product Preparation and Packaging
,
Pharmaceutical and Medicine Manufacturing
,
Animal aquaculture
,
Fresh or frozen packaged fish
See All Industries Diagnostic substances
See Fewer Industries
See All Industries Diagnostic substances
See Fewer Industries
Cattle Ranching and Farming
,
Fishing
,
Forest Nurseries and Gathering of Forest Products
,
Fruit and Tree Nut Farming
,
Greenhouse, Nursery, and Floriculture Production
,
Hog and Pig Farming
,
Hunting and Trapping
,
Logging
View more , Oilseed and Grain Farming , Other Animal Production , Other Crop Farming , Poultry and Egg Production , Sheep and Goat Farming , Support Activities for Animal Production , Support Activities for Crop Production , Support Activities for Forestry , Timber Tract Operations Vegetable and Melon Farming
View fewer
View more , Oilseed and Grain Farming , Other Animal Production , Other Crop Farming , Poultry and Egg Production , Sheep and Goat Farming , Support Activities for Animal Production , Support Activities for Crop Production , Support Activities for Forestry , Timber Tract Operations Vegetable and Melon Farming
View fewer
?
?
?
Actual
?
Actual
$46.95 million
Actual
-22.2%
$1,821
DEC
?
?
Shenzhen:002086
Contacts
Get in Touch with 11 Principals*
-
Le ZhangLegal Representative
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$46.95 million
USD
Actual
1 USD = 7.2455 CNY
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | -$27 | -$6 | -$6 |
| Net Investing Cash | -$4 | -$2 | -$4 |
| Net Financing Cash | $30 | $11 | -$3 |
| Net Change in Cash | -$0 | $2 | -$13 |
| Cash at Beginning of Period | $19 | $17 | $29 |
| Cash at End of Period | $20 | $19 | $17 |
| Capital Expenditure | -$4 | -$2 | -$4 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $56 | $178 | $18 |
| Accounts Receivable | $10 | $7 | $32 |
| Inventories | $30 | $18 | $25 |
| Other Current Assets | $4 | $2 | $4 |
| Asset Summary | |||
| Total Current Assets | $100 | $205 | $80 |
| Tangible Fixed Assets | $130 | $143 | $165 |
| Intangible Assets | $9 | $12 | $17 |
| Total Assets | $1,822 | $2,708 | $2,002 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $14 | $12 | $27 |
| Short-Term Debt | $1 | $1 | $58 |
| Other Current Liabilities | $15 | $94 | $140 |
| Liability Summary | |||
| Total Current Liabilities | $29 | $106 | $225 |
| Long-Term Debt | $ | $6 | $4 |
| Other Long-Term Liabilities | $3 | $4 | $176 |
| Total Liabilities | $52 | $149 | $436 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $270 | $270 | $104 |
| Retained Earnings | -$349 | -$323 | -$564 |
| Equity Summary | |||
| Total Equity | $198 | $223 | -$161 |
| Shares Outstanding | 1,958,946,500 | 1,958,946,500 | 756,350,000 |